Logo-jre
Submitted: 02 Oct 2024
Accepted: 05 Nov 2024
ePublished: 30 Nov 2024
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Ren Endocrinol. 2024;10: e25174.
doi: 10.34172/jre.2024.25174
  Abstract View: 41
  PDF Download: 47

Mini-Review

Renal manifestations of hemochromatosis; an update to recent findings

Shahrzad Alimohammadi 1,2 ORCID logo, Nahid Moradi 3 ORCID logo, Nabiha Midhat Ansari 4 ORCID logo, Ali Shirbacheh 5 ORCID logo, Kamran Shirbache 6* ORCID logo

1 Doctoral School of Molecular Medicine, University of Debrecen, 4032 Debrecen, Hungary.
2 Department of Immunology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
3 School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
4 Faculty of Medicine, Medical University - Plovdiv, Plovdiv, Bulgaria.
5 Urgences, Centre Hospitalier de l’Agglomération de Nevers, Nevers, France.
6 Hôpital Robert Debré, Groupe Hospitalier Universitaire AP-HP Nord-Université Paris-Cité, France.
*Corresponding Author: Kamran Shirbache, Email: Kamranshirbache@gmail.com

Abstract

Hemochromatosis is a genetic disorder that results in excessive iron absorption, followed by iron overload in various organs including the kidneys. IgA nephropathy, on the other hand, is the immunoglobulin A (IgA) deposition in the glomeruli mesangium. Hemochromatosis-associated IgA nephropathy is a condition described as both hemochromatosis and IgA nephropathy in an individual. Recently, there has been growing evidence suggesting a potential association between IgA nephropathy and hemochromatosis. Previous studies have indicated that individuals with hemochromatosis may have an increased risk of developing IgA nephropathy. Some studies suggest a higher prevalence of hemochromatosis-associated gene mutations particularly HFE gene mutations, in IgA nephropathy patients. These gene mutations may affect iron metabolism and contribute to the development of both conditions. Excessive iron in the kidney may also be associated with increasing inflammatory response and IgA deposition in the glomeruli. Treatment options for hemochromatosis-associated IgA include corticosteroids, RAS blockade, immunosuppressive agents, and supportive care for chronic kidney disease.

Citation: Alimohammadi Sh, Moradi N, Midhat Ansari N, Shirbacheh A, Shirbache K. Renal manifestations of hemochromatosis; an update to recent findings. J Ren Endocrinol. 2024;10:e25174. doi: 10.34172/jre.2024.25174.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 40

Your browser does not support the canvas element.


PDF Download: 47

Your browser does not support the canvas element.